Immunohistochemical patterns differ between medullary carcinoma and other poorly differentiated adenocarcinomas.8) Medullary carcinoma often shows loss of MLH1 and PMS2, whereas poorly differentiated adenocarcinomas typically do not. This evidence concerns the gene MLH1 and medullary thyroid gland carcinoma.